Antimycobacterial screening of traditional medicinal plants using the microplate resazurin assay

• Published in: Canadian Journal of Microbiology
• Main Authors: Webster, Duncan, Lee, Timothy D.G., Moore, Jill, Manning, Tracy, Kunimoto, Dennis, LeBlanc, Darren, Johnson, John A., Gray, Christopher A.
• Format: Article in Journal/Newspaper
• Language: English
• Published: Canadian Science Publishing 2010
• Subjects: First Nations
• Online Access: http://dx.doi.org/10.1139/w10-035; http://www.nrcresearchpress.com/doi/full-xml/10.1139/W10-035; http://www.nrcresearchpress.com/doi/pdf/10.1139/W10-035

Multidrug-resistant Mycobacterium tuberculosis strains have rapidly become a global health concern. North American First Nations communities have used traditional medicines for generations to treat many pulmonary infections. In this study, we evaluated the antimycobacterial activity of 5 medicinal plants traditionally used as general therapeutics for pulmonary illnesses and specifically as treatments for tuberculosis. Aqueous extracts of Aralia nudicaulis , Symplocarpus foetidus , Heracleum maximum , Juniperus communis, and Acorus calamus were screened for antimycobacterial activity against Bacillus Calmette–Guérin, Mycobacterium avium, and M. tuberculosis H37Ra using the colorimetric microplate resazurin assay. Extracts of Acorus calamus and H. maximum root demonstrated significant antimycobacterial activity comparable to that of the rifampin control (2 µg/mL). Evaluation of the cytotoxicity of these 2 extracts using the MTT assay also showed that the extracts were less toxic to 3 human cell lines than was the DMSO positive control. This study demonstrates that aqueous extracts of the roots of H. maximum and Acorus calamus possess strong in vitro antimycobacterial activity, validates traditional knowledge, and provides potential for the development of urgently needed novel antituberculous therapeutics.